Literature DB >> 26050631

Ribonuclease-neutralized pancreatic microsomal membranes from livestock for in vitro co-translational protein translocation.

Kurt Vermeire1, Susanne Allan2, Becky Provinciael3, Enno Hartmann2, Kai-Uwe Kalies2.   

Abstract

Here, we demonstrate that pancreatic microsomal membranes from pigs, sheep, or cattle destined for human consumption can be used as a valuable and ethically correct alternative to dog microsomes for cell-free protein translocation. By adding adequate ribonuclease (RNase) inhibitors to the membrane fraction, successful in vitro co-translational translocation of wild-type and chimeric pre-prolactin into the lumen of rough microsomes was obtained. In addition, the human type I integral membrane proteins CD4 and VCAM-1 were efficiently glycosylated in RNase-treated microsomes. Thus, RNase-neutralized pancreatic membrane fractions from pig, cow, or sheep are a cheap, easily accessible, and fulfilling alternative to canine microsomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell-free protein translation; Cyclotriazadisulfonamide (CADA); Mammalian ER membranes; Pancreatic microsomes; Ribonuclease; Translocation inhibitor

Mesh:

Substances:

Year:  2015        PMID: 26050631     DOI: 10.1016/j.ab.2015.05.019

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Biochemical and Biological Assays of Mycolactone-Mediated Inhibition of Sec61.

Authors:  Sarah O'Keefe; Stephen High; Caroline Demangel
Journal:  Methods Mol Biol       Date:  2022

2.  Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide.

Authors:  Victor Van Puyenbroeck; Eva Pauwels; Becky Provinciael; Thomas W Bell; Dominique Schols; Kai-Uwe Kalies; Enno Hartmann; Kurt Vermeire
Journal:  Traffic       Date:  2019-11-25       Impact factor: 6.215

3.  Proteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature.

Authors:  Jean-David Morel; Anja O Paatero; Jiajie Wei; Jonathan W Yewdell; Laure Guenin-Macé; Delphi Van Haver; Francis Impens; Natalia Pietrosemoli; Ville O Paavilainen; Caroline Demangel
Journal:  Mol Cell Proteomics       Date:  2018-06-18       Impact factor: 5.911

4.  Coibamide A Targets Sec61 to Prevent Biogenesis of Secretory and Membrane Proteins.

Authors:  Dale Tranter; Anja O Paatero; Shinsaku Kawaguchi; Soheila Kazemi; Jeffrey D Serrill; Juho Kellosalo; Walter K Vogel; Uwe Richter; Daphne R Mattos; Xuemei Wan; Christopher C Thornburg; Shinya Oishi; Kerry L McPhail; Jane E Ishmael; Ville O Paavilainen
Journal:  ACS Chem Biol       Date:  2020-07-20       Impact factor: 5.100

5.  Use of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting/translocation pathway.

Authors:  Wolfgang Klein; Claudia Rutz; Jamina Eckhard; Becky Provinciael; Edgar Specker; Martin Neuenschwander; Gunnar Kleinau; Patrick Scheerer; Jens-Peter von Kries; Marc Nazaré; Kurt Vermeire; Ralf Schülein
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

6.  Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes.

Authors:  Elisa Claeys; Eva Pauwels; Stephanie Humblet-Baron; Becky Provinciael; Dominique Schols; Mark Waer; Ben Sprangers; Kurt Vermeire
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.